You are here

Article info

Article menu
Immunotherapy biomarkers
Original research
Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma

Authors

  • Chengpei Zhu Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, ChinaDepartment of General Surgery Center, Beijing Youan Hospital, Clinical Center for Liver Cancer, Capital Medical University, Beijing, China PubMed articlesGoogle scholar articles
  • Chenchen Zhang Microbiome Research Center, Moon (Guangzhou) Biotech Ltd, Guangzhou, China PubMed articlesGoogle scholar articles
  • Shanshan Wang Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China PubMed articlesGoogle scholar articles
  • Ziyu Xun Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China PubMed articlesGoogle scholar articles
  • Dongya Zhang Microbiome Research Center, Moon (Guangzhou) Biotech Ltd, Guangzhou, China PubMed articlesGoogle scholar articles
  • Zhou Lan Microbiome Research Center, Moon (Guangzhou) Biotech Ltd, Guangzhou, China PubMed articlesGoogle scholar articles
  • Longhao Zhang Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China PubMed articlesGoogle scholar articles
  • Jiashuo Chao Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China PubMed articlesGoogle scholar articles
  • Yajun Liang Microbiome Research Center, Moon (Guangzhou) Biotech Ltd, Guangzhou, China PubMed articlesGoogle scholar articles
  • Zilun Pu Microbiome Research Center, Moon (Guangzhou) Biotech Ltd, Guangzhou, China PubMed articlesGoogle scholar articles
  • Cong Ning Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China PubMed articlesGoogle scholar articles
  • Xinting Sang Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China PubMed articlesGoogle scholar articles
  • Xiaobo Yang Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China PubMed articlesGoogle scholar articles
  • Hanping Wang Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, ChinaDepartment of Pulmonary and Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Beijing, China PubMed articlesGoogle scholar articles
  • Xianzhi Jiang Microbiome Research Center, Moon (Guangzhou) Biotech Ltd, Guangzhou, China PubMed articlesGoogle scholar articles
  • Haitao Zhao Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China PubMed articlesGoogle scholar articles

Citation

Zhu C, Zhang C, Wang S, et al
Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma
Journal for ImmunoTherapy of Cancer 2024;12:e008686. doi: 10.1136/jitc-2023-008686
Online issue publication 
June 06, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.